Recall365
Recalls › Australia › CHEMISTS' OWN PROVANCE Immune Defence & 28 PLUS Immune Defe…

CHEMISTS' OWN PROVANCE Immune Defence & 28 PLUS Immune Defence — recall

Health products · Australia · 2026-10-01

CHEMISTS' OWN PROVANCE Immune Defence products, allergic reaction risk

→ See all Arrotex Pharmaceuticals recalls

CountryAustralia
CategoryHealth products
Published2026-10-01
CompanyArrotex Pharmaceuticals Pty Ltd
Batch / expiryProduct Codes: 7010029 & 7019041; All batches within expiry
Product typeMedicine
Registration no. (ARTG)303672, 519427
Recall levelConsumer
Hazard classClass I
ReasonSince 2019, listed medicines containing Andrographis paniculata (Andrographis) for supply in Australia have been required to carry a label warning about the risk of allergic reactions including severe reactions such as anaphylaxis. However, despite these warnings, the TGA has continued to receive a sustained high number of reports of anaphylaxis associated with Andrographis-containing listed medicines, which are considered low-risk medicines. Andrographis has now been removed from the Therapeutic Goods (Permissible Ingredients) Determination (No. 2) 2026. This means the ingredient is no lon…
Recall typeRecall
RemedyDistributors/Wholesalers • Inspect stock immediately and quarantine all stock of product on hand to prevent further use or distribution. • Please return all affected stock to Arrotex • Be aware that as the Recall is also being performed at Pharmacy and Consumer levels stock will be returned stock to you. Pharmacists • Inspect stock immediately and quarantine all stock of product on hand to prevent further use or distribution. • Contact your Wholesaler to arrange for the return of the stock and a suitable refund will be applied. • Retailers are recommended to place the ‘Consumer Notice’ at…
Affected areaAustralia
Recall numberRC-2026-RN-00762-1
Official noticeView source ↗

Get alerted when Arrotex Pharmaceuticals has another recall

Free: we'll email you when Arrotex Pharmaceuticals appears in a new official recall across 11 markets, including the US, EU and Japan.

Watch Arrotex Pharmaceuticals recalls — free →

What this means for sellers

Likely platform / channel actionsRetailers/importers typically pull and return stock; similar products may face tighter border checks.
Self-check for comparable productsCheck your comparable products' design, materials and QC records against the defect described here.
Rules & standards likely involvedthe destination market's product-safety rules and mandatory standards

🚨 Delisted or named by a regulator? Leave your details and situation — we'll assess and get back to you. Contact us →

General guidance only — not compliance or legal advice; the official notice and applicable law prevail.

Stay ahead of recalls like this

Get overseas recalls that matter to you (China-origin highlighted) + top hazards — one email a week. Free, unsubscribe anytime.

By subscribing you agree to our Privacy Policy & Terms (incl. cross-border data processing).

Or search & set alerts — free →

Related health products recalls